Yonah C. Ziemba

Yonah C. Ziemba

Auto-generated profile, based on publicly available information

Yonah C. Ziemba

Northwell Health, Department of Pathology and Laboratory Medicine , New Hyde Park, New York

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2020 in Transfusion
Verified
Journal Article
Closed access
PDF file
YZYonah Ziemba
Yonah Ziemba
CXCindy Xu
Cindy Xu
KFKatayoun M. Fomani
Katayoun M. Fomani
VNVijay Nandi
Vijay Nandi
TYTiejun Yuan
Tiejun Yuan
PSPatricia Shi
Patricia Shi

28 August 2021 in Haemophilia
Verified
Journal Article
Closed access
PDF file
JAJameel Abdulrehman
Jameel Abdulrehman
YZYonah C. Ziemba
Yonah C. Ziemba
PHPeihong Hsu
Peihong Hsu
ECElizabeth M. Van Cott
Elizabeth M. Van Cott
EPElizabeth A. Plumhoff
Elizabeth A. Plumhoff
RSRita Selby
Rita Selby

1 January 2020 in Academic Pathology
Verified
Journal Article
Open access
PDF file
YZYonah C. Ziemba
Yonah C. Ziemba
DRDana Razzano
Dana Razzano
TATimothy C. Allen
Timothy C. Allen
ABAdam Booth
Adam Booth
SAScott R. Anderson
Scott R. Anderson
PMPriscilla S. Markwood
Priscilla S. Markwood
The use of social media at academic conferences is expanding, and platforms such as Twitter are used to share meeting content with the world. Pathology conferences are no exception, and recently, pathology organizations have promoted social media as a way to enhance meeting exposure. A social media committee was formed ad hoc to implement strategies to enhance social media involvement and coverage at the 2018 and 2019 annual meetings of the Association of Pathology Chairs. This organized approach resulted in an 11-fold increase in social media engagement compared to the year prior to committee formation (2017). In this article, the social media committee reviews the strategies that were employed and the resultant outcome data. In addition, we categorize tweets by topic to identify the topics of greatest interest to meeting participants, and we discuss the differences between Twitter and other social media platforms. Lastly, we review the existing literature on this topic from 23 medical specialties and health care fields.

1 January 2020 in Academic Pathology
Verified
Journal Article
Open access
PDF file
DRDana Razzano
Dana Razzano
YZYonah C. Ziemba
Yonah C. Ziemba
ABAdam Booth
Adam Booth
PMPriscilla Markwood
Priscilla Markwood
CHChristina T. Hanos
Christina T. Hanos
NRNicole Riddle
Nicole Riddle
Participants at academic conferences frequently use social media to disseminate educational content learned while at the meeting. Although most agree that this activity is harmless, some have expressed concern regarding the accuracy of the shared content and whether it truly reflects the intent and message of the speaker. As part of the goals of the APC 2018 social media committee to promote excellence through social media, a study was conducted to measure the perceived accuracy of tweets that represented an opinion or statement from a speaker and was shared during the annual meeting. Tweets shared on Twitter using the meeting hashtag (#APCPRODS2018) were collected and a survey unique to each speaker was created, to which 54% responded. The majority of speakers regarded the use of Twitter at the conference as beneficial in spreading their intended message in an accurate way. This study exemplifies the positive impact that social media use can have at academic meetings.

1 January 2018 in Journal of Pathology Informatics
Verified
Journal Article
Open access
PDF file
YZYonah C. Ziemba
Yonah C. Ziemba
LLLiya Lomsadze
Liya Lomsadze
YJYehuda Jacobs
Yehuda Jacobs
TCTylis Y. Chang
Tylis Y. Chang
NHNina Haghi
Nina Haghi
Background: When a provider orders a test in a pattern that is substantially different than their peers, it may indicate confusion in the test name or inappropriate use of the test, which can be elucidated by initiating dialog between clinicians and the laboratory. However, the analysis of ordering patterns can be challenging. We propose a utilization index (UI) as a means to quantify utilization patterns for individual providers and demonstrate the use of heatmaps to identify opportunities for improvement. Materials and Methods: Laboratory test orders by all providers were extracted from the laboratory information system. Providers were grouped into cohorts based on the specialty and patient population. A UI was calculated for each provider's use of each test using the following formula: (UI = [provider volume of specific test/provider volume of all tests]/[cohort volume of specific test/cohort volume of all tests]). A heatmap was generated to compare each provider to their cohort. Results: This method identified several hot spots and was helpful in reducing confusion and overutilization. Conclusion: The UI is a useful measure of test ordering behavior, and heatmaps provide a clear visual illustration of the utilization indices. This information can be used to identify areas for improvement and initiate meaningful dialog with providers, which will ultimately bring improvement and reduction in costs. Our method is simple and uses resources that are widely available, making this method effective convenient for many other laboratories.

23 December 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Closed access
JCJames M Crawford
James M Crawford
LPLynne Penberthy
Lynne Penberthy
LPLigia A Pinto
Ligia A Pinto
KAKeri N Althoff
Keri N Althoff
MAMagdalene M Assimon
Magdalene M Assimon
YZYonah C Ziemba
Yonah C Ziemba
Background: We developed a United States–based real-world data resource to better understand the continued impact of the coronavirus disease 2019 (COVID-19) pandemic on immunocompromised patients, who are typically underrepresented in prospective studies and clinical trials. Methods: The COVID-19 Real World Data infrastructure (CRWDi) was created by linking and harmonizing de-identified HealthVerity medical and pharmacy claims data from 1 December 2018 to 31 December 2023, with severe acute respiratory syndrome coronavirus 2 virologic and serologic laboratory data from major commercial laboratories and Northwell Health; COVID-19 vaccination data; and, for patients with cancer, 2010 to 2021 National Cancer Institute Surveillance, Epidemiology, and End Results registry data. Results: The CRWDi contains 4 cohorts: patients with cancer; patients with rheumatic diseases receiving pharmacotherapy; noncancer solid organ and hematopoietic stem cell transplant recipients; and people from the general population including adults and pediatric patients. The project successfully linked and harmonized longitudinal, de-identified data on 5.2 million unique patients using privacy-preserving record lineage techniques. The system was developed in early 2024 and rapidly deployed, enabling longitudinal analysis of patient healthcare over the full geography of delivery settings and exploration of novel questions for populations at high risk for adverse outcomes. Conclusions: The successful development of the CRWDi enables researchers to address unanswered questions that have arisen during the COVID-19 pandemic. By making the data broadly and freely available to academic researchers, this real-world data system represents an important complement to existing consortia and clinical trials that have emerged during the healthcare crisis and is readily reproducible for future purposing.